Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The America Watch.
Press releases published on May 2, 2025

CBD Care Unveils Bliss CBD Gummies: A Natural Remedy to Relieve Stress, Pain, and Sleeplessness
HACKENSACK, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- CBD Care, a trusted name in natural wellness, introduces Bliss CBD Gummies—a revolutionary product designed to provide relief from stress, chronic pain, and sleeplessness. With growing concerns around …

EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025
Glasgow, Scotland – 2 May 2025. EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced that results from its IMPuLCE Phase 1b trial evaluating EBX-102, …

Polana Launches AI-Driven DeFi Platform and Starts POLAI Token ICO/Presale
Phoenix, AZ, May 02, 2025 (GLOBE NEWSWIRE) -- Polana Labs (POLAI), an AI-powered DeFi platform, has officially launched, boasting automated, AI-driven investment tools that help users optimize their crypto portfolios. Simultaneously with its launch, Polana …

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025
Tokyo, Japan and Cambridge, UK, 2 May 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2025. The full report can be found here. …

OBI Pharma gibt bekannt, dass die US-Arzneimittelbehörde FDA den IND-Antrag für eine Phase-1/2-Studie mit OBI-902, einem Trop-2-gerichteten ADC, genehmigt hat
TAIPEI, Taiwan, May 02, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. („OBI“), ein Onkologieunternehmen in der klinischen Phase (4174.TWO), hat heute bekannt gegeben, dass die US-amerikanische Arzneimittelbehörde FDA (Food and Drug Administration) den Antrag …

OBI Pharma reçoit l’approbation de la FDA à la suite de sa demande d’étude clinique de la Phase I/II pour OBI-902, un CAM ciblant Trop-2
TAIPEI, Taïwan, 02 mai 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (« OBI »), un laboratoire d’oncologie au stade clinique (4174.TWO), annonce ce jour que l’Agence américaine des produits alimentaires et médicamenteux, la Food and Drug Administration, ou « …

Snail Games 发布捷报,2025 年 4 月攻势如虹:王牌 IP 开疆拓土,独立恐怖 IP 新作面世,战略发行高歌猛进
卡尔弗城,加利福尼亚州, May 02, 2025 (GLOBE NEWSWIRE) -- 作为全球领先的互动数字娱乐独立开发商和发行商,Snail, Inc. (Nasdaq: SNAL,以下简称“Snail Games”或“公司”) 今日公布了其 2025 年 4 月的卓越战绩,包括 ARK 系列的持续扩张,Bellwright 里程碑式的内容更新,以及该公司的独立游戏发行品牌 Wandering Wizard 旗下多款 IP 的发布。 ARK 系列内容焕新,魅力加倍 Snail Games …

Snail Games 報告稱 2025 年 4 月主要特許經營的擴展、新獨立恐怖 IP 發布及策略性發布增長帶來強大動力
卡爾弗城,加州, May 02, 2025 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商和發行商 Snail, Inc. (Nasdaq: Snal) (「Snail Games」或「公司」),今天重點介紹了其產品組合在 2025 年 4 月份的主要進程,包括 ARK 系列的擴展、Bellwright 的內容進程,以及公司獨立發行商品牌 Wandering Wizard 旗下的多個 IP 發布。 ARK 系列憑藉全新內容得以更上一層樓 Snail Games …

Kyndryl Investor News: If You Have Suffered Losses in Kyndryl Holdings, Inc. (NYSE: KD), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kyndryl Holdings, Inc. (NYSE: KD) resulting from allegations that …

SWKS DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Skyworks Solutions, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – SWKS
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skyworks Solutions, Inc. (NASDAQ: SWKS) between July 30, 2024 and February 5, 2025, both dates inclusive (the “Class …

UMH PROPERTIES, INC. REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 (UPDATED)
FREEHOLD, NJ, May 01, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on May 1, 2025 by UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), please note that for the Full Year Guidance 2025 section in Note 3, “Net Loss Attributable to Common …

GlucoBerry Under Review: MD/Process Doctor-Formulated Blood Sugar Drain for Glucose Support
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why blood sugar imbalances are becoming more common, and what symptoms may indicate a deeper glucose management issue How the kidneys and a little-known "blood sugar drain" …

CoolEase Under Review: Fast-Acting Long Term Minor Aches & Pain Relief Soothing Cream
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: What causes minor aches, muscle tension, and joint pain in today’s fast-paced environment Why traditional pain relief solutions often fall short for long-term comfort How CoolEase …

BalMorex Pro Under Review: Fast-Acting Relief & Recovery Pain Cream for Joints & Muscles Released
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: What causes joint and muscle discomfort in daily life—and why so many treatments fall short Why inflammation is a major trigger for pain and how natural solutions can help How …

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ultra Clean Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UCTT
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) between May 6, 2024 to February 24, 2025, both dates inclusive (the “Class …

OPEN LENDING ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Open Lending Corporation and Encourages Investors to Contact the Firm
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …

First National Bank Alaska Declares Dividend for Second Quarter 2025
ANCHORAGE, Alaska, May 01, 2025 (GLOBE NEWSWIRE) -- At the Board of Directors Meeting held April 30, 2025, a cash dividend of $4.00 per share was declared, payable on June 15, 2025, and distributed on June 16, 2025, to shareholders of record as of June 1, …

LottoChamp Under Review: Best Way to Become a Smart Lottery Champion Winner
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why most lottery players rely on luck and end up with repeated losses The biggest frustrations and financial pain points faced by traditional lottery participants How LottoChamp …

Flow Force Max Under Review: Natural Chewable Candy Ingredients to Support Prostate Health for Men
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why FlowForce Max is gaining attention as a complete, natural prostate support supplement for men over 40 How FlowForce Max uses a 3-phase male vitality protocol to target …

Fluxactive Under Review: The Complete Prostate Wellness Formula for Bladder Support
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: What Fluxactive Complete is and how it supports long-term prostate health naturally The full list of Fluxactive Complete ingredients and how each one contributes to better urinary …